Quarterly Consolidated Statement Of Cash Flows

HISAMITSU PHARMACEUTICAL CO.,INC. - Filing #7362167

Concept 2023-03-01 to
2023-11-30
2022-03-01 to
2022-11-30
Quarterly consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
16,659,000,000 JPY
13,029,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.